The global electronic data capture systems market size is anticipated to reach USD 3.63 billion by 2030, expanding at a CAGR of 14.6%, according to a new report by Grand View Research, Inc. The key factors driving the market growth include the digitalization of clinical trials, increasing R&D investments, adoption of eClinical solutions, and the need to standardize data collection and quality checks. EDC systems improve information management and analysis, accelerate the timeline for clinical trial approval, and support faster decision-making pertaining to product approval procedures. Medical device manufacturers, CROs, and biopharmaceutical companies are adopting these solutions to save the cost and time spent on clinical trial data management.
Clinical trial operations were significantly impacted due to the COVID-19 pandemic. In fact, an estimated 12% of clinical trial activity was paused according to a survey published by Oracle in 2021. However, the pandemic also catalyzed the adoption of clinical trials automation, operation, and data management technologies such as teleconsultations, EHR, remote monitoring, digital consent, and clinical data capture & management systems. Around 76% of the respondents comprising representatives from the pharma & biotech industry, the medical devices industry, and CROs reported that the COVID-19 public health emergency accelerated their usage of decentralized clinical trial methods. This is estimated to fuel the demand for EDC systems as the management of clinical trials continues to undergo digitalization post-COVID.
The associated benefits of an eClinical solution, or EDC as part of an eClinical solution, are also expected to increase the adoption of such solutions in the coming years. These include recommendations on the medical interpretation of emergent findings, the use of AI and analytics, and the elimination of data discrepancies. The other benefits of adopting EDC systems include advanced statistical analysis and improved compilation of technical & scientific data required for the fulfillment of regulatory prerequisites of clinical trials. The growing awareness pertaining to the advantages of EDC services over paper-based clinical information management is a major factor contributing to the growth of this market.
Moreover, the rising trend of outsourcing across the healthcare IT services industry creates more avenues for contract research organizations to enter into the eClinical solutions marketplace. The increasing number of decentralized clinical trials also presents lucrative opportunities for market players active in the EDC systems market. Growing adoption of cloud-based services, rising interoperability, and product upgrades are other factors attributing to the market growth over the forecast period. In addition, increasing competition amongst the major pharmaceutical companies is urging them to expand their R&D budgets, thus resulting in a greater number of clinical studies. Also, the increasing number of patent expirations is another factor contributing to the increase in the number of clinical studies for drug development and discovery. This is anticipated to propel the demand for EDC systems.
Request a free sample copy or view report summary: Electronic Data Capture Systems Market Report
The Electronic Data Capture (EDC) Systems market was valued at USD 1.25 billion in 2022 and is expected to expand at a CAGR of 14.6% during the forecast period
The need to increase the efficiency of data collection and enhance the overall data quality is expected to drive market growth during the forecast period
Services dominated the market by component in 2022, while the software segment is estimated to grow the fastest. Consultation services for EDC installation and data support and management are some of the key services offered to EDC system customers
The web & cloud-based segment held the largest share of the market by delivery mode in 2022. It is also expected to grow the fastest in the coming years
Factors attributing to the growth of web & cloud-based EDC systems include real-time data capture, real-time data transfer, immediate feedback, faster data cleaning, and scalability
Castor, for example, offers a cloud-based clinical data management platform that includes EDC, ePRO, eCOA, eConsent, eSource, and decentralized trial solutions. This facilitates the easy capture and integration of data received from patients, devices, clinicians, wearables, and EHR systems
EDC systems also help in minimizing the errors that may occur during manual data entry. Also, the use of these solutions enables considerable savings of time and research-associated costs. This is expected to drive market growth during the forecast period
Grand View Research has segmented the global electronic data capture systems market based on delivery mode, component, development phase, end-user, and region:
Electronic Data Capture Systems Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)
On-premise
Web & Cloud-based
Electronic Data Capture Systems Component Outlook (Revenue, USD Million, 2018 - 2030)
Software
Services
Electronic Data Capture Systems Development Phase Outlook (Revenue, USD Million, 2018 - 2030)
Phase I
Phase II
Phase III
Phase IV
Electronic Data Capture Systems End-user Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals/Healthcare providers
CROs
Pharmaceutical and Biotechnology Firms
Medical Device Firms
Others
Electronic Data Capture Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
List of Key Players in the Electronic Data Capture Systems Market
Calyx
Castor
OpenClinica, LLC
IBM
IQVIA Inc.
Medidata Solutions, Inc.
Oracle
DATATRAK International, Inc.
Clario
Veeva Systems
"The quality of research they have done for us has been excellent..."